TegoScience Inc.

A191420

KR7191420009

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 03/07/2024 am IST			5-day change	1st Jan Change
18,810 ^KRW	-1.26%		+5.73%	+28.31%

2023	TegoScience Inc.(KOSDAQ:A191420) dropped from S&P Global BMI Index	CI
2023	TegoScience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

TegoScience Inc.(KOSDAQ:A191420) added to S&P Global BMI Index

September 19, 2016 at 09:30 am IST

Latest news about TegoScience Inc.

TegoScience Inc.(KOSDAQ:A191420) dropped from S&P Global BMI Index	18/23/18	CI
TegoScience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	22/23/22	CI
TegoScience Inc.'s Equity Buyback announced on March 16, 2020, has expired.	15/22/15	CI
TegoScience Inc.'s Equity Buyback Plan Extended till September 15, 2021.	15/21/15	CI
TegoScience Inc.'s Equity Buyback Plan Extended till March 15, 2021.	15/20/15	CI
Tranche Update on TegoScience Inc.'s Equity Buyback Plan announced on March 16, 2020.	19/20/19	CI
TegoScience Inc. announces an Equity Buyback for KRW 2,000 million worth of its shares.	16/20/16	CI
Tego Science, Inc. authorizes a Buyback Plan.	16/20/16	CI
TegoScience Inc. announced that it has received KRW 15 billion in funding from Korea Investment Capital Co., Ltd, LIG Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm	21/16/21	CI
TegoScience Inc. announced that it expects to receive KRW 15 billion in funding from Korea Investment Capital Co., Ltd, LIG Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm	19/16/19	CI
TegoScience Inc.(KOSDAQ:A191420) added to S&P Global BMI Index	19/16/19	CI
TegoScience Inc. announced that it has received KRW 1 billion in funding	29/16/29	CI
TegoScience Inc. announced that it expects to receive KRW 1 billion in funding	27/16/27	CI
National Pension Service and a related party acquired 5.21% stake in TegoScience Inc..	08/15/08	CI
TegoScience Inc. has completed an IPO in the amount of KRW 7,191.44 million.	04/14/04	CI
TegoScience Inc. has filed an IPO in the amount of KRW 6,658 million.	10/14/10	CI

Tego Science,Inc. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of wound-healing skin cell therapy products. The Companyâs products mainly consist of cell therapy products, and laboratory cultured skin models.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
TEGOSCIENCE INC.	+28.31%	110M
CSL LIMITED	+3.82%	93.97B
SAMSUNG BIOLOGICS CO.,LTD.	+6.58%	41.61B
BIOGEN INC.	-13.20%	33.32B
UCB	+77.12%	28.8B
BIOMARIN PHARMACEUTICAL INC.	-16.02%	15.61B
INCYTE CORPORATION	-8.17%	13.27B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.49%	11.46B
ALTEOGEN INC.	+162.44%	10.06B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54.92%	9.09B